Some news from Xolo: they want to go into outer space!
biotech
Nano Dimension Cancels Shareholder Meeting as Four Directors and CEO Exit
Another week, another major development at Nano Dimension, which throws everything said previously upside down.
The Biotech Investment Backstop — And What It Means for 3D Printing
Charles R. Goulding and Preeti Sulibhavi demonstrate how biotech is getting a boost from stronger pharma buyers, smarter use of 3D printing, and new OBBBA tax incentives that make early-stage R&D far easier to fund.
From Wet Labs to 3D Printing: NYU Langone Powers NYC’s Medical Renaissance
Charles R. Goulding and Kate Esposito delve into how NYU Langone is reshaping New York City’s medical innovation landscape through cutting-edge research centers, 3D printing advancements, and programs empowering the next generation of healthcare entrepreneurs.